Mounjaro and Menstrual Bleeding: What the Evidence Says

Step 1: Understanding why the cycle shifts in the first place

Tirzepatide does not directly target reproductive hormones. What it does, quickly and effectively in many people, is reduce body fat. Fat tissue is metabolically active, it both stores and produces oestrogen, and the amount of fat you carry influences the balance of hormones that regulate your cycle. As that fat mass changes, oestrogen levels adjust, and the hypothalamic-pituitary-ovarian axis (the hormonal loop that governs ovulation and menstruation) recalibrates too.

This recalibration can go in more than one direction. Women who carry higher levels of body fat sometimes experience heavier or more frequent periods before treatment; rapid weight loss can initially intensify this before cycles settle. Others find periods lighten, space out, or arrive erratically during the early months of treatment. Neither pattern is unique to Mounjaro, similar reports appear with semaglutide and with significant weight loss achieved by any route.

The NHS notes that body-weight changes affect hormone balance, and this is one reason why Mounjaro's effect on the menstrual cycle is discussed separately from its licensed side-effect profile. The licensed profile, detailed on the tirzepatide page, centres on gastrointestinal effects; cycle changes are not among the listed adverse reactions in the Mounjaro SmPC.

Step 2: The contraception question, a specific and important one

If you take a combined or progesterone-only oral contraceptive pill, Mounjaro introduces a practical complication worth knowing about before you notice anything. Tirzepatide slows gastric emptying as part of how it reduces appetite. That slower transit can reduce how much of an oral medicine is absorbed, and the pill is among those affected.

NHS guidance is clear: add a non-oral contraceptive method (condoms are the straightforward choice) for the first four weeks of starting Mounjaro, and again for four weeks after every dose increase. This applies at each step up the titration schedule. Once you have been stable at a given dose for four weeks, your usual pill alone is considered sufficient again.

There is no equivalent warning for semaglutide (Wegovy), because the evidence for reduced pill absorption has been identified specifically for tirzepatide. If you use a patch, implant, injection, hormonal coil or non-hormonal method, this four-week rule does not apply to you, though it is always worth mentioning any new prescription to whoever manages your contraception. Wondering whether HRT is affected by the same mechanism? The Mounjaro and HRT bleeding page covers that in detail.

Step 3: Spotting the difference between an expected change and one that needs attention

Most cycle changes in the early months of Mounjaro treatment are a nuisance rather than a danger. They tend to stabilise as weight loss slows and the body adjusts to its new hormonal baseline. Keeping a simple note in your phone (dates, flow, anything unusual) takes about thirty seconds after you take your weekly pen from the fridge door and can be genuinely useful if you later speak to your GP or prescriber.

There are patterns that should prompt you to seek medical advice promptly, not because they are necessarily caused by Mounjaro, but because they warrant investigation regardless of what else is going on:

• Bleeding that is significantly heavier than your usual pattern, lasting more than seven days, or soaking through protection in an hour or less.
• Bleeding between periods (intermenstrual bleeding) that is new or persistent.
• Post-menopausal bleeding, any bleeding after twelve consecutive period-free months.
• Pelvic pain accompanying changed bleeding.

These are not signals to stop your treatment unilaterally, that is a decision for your prescriber. They are signals to get checked. You can read more about the broader category of bleeding on Mounjaro and what has been reported by people in treatment. The can Mounjaro cause bleeding page addresses specific questions about causation.

Step 4: Fertility, irregular cycles, and conditions like PCOS

For women who have experienced irregular or absent periods due to higher body weight (particularly those with polycystic ovary syndrome) weight loss can restore or regularise ovulation before they expect it. This is medically positive but practically significant: if you had assumed irregular cycles meant low fertility risk, that assumption may no longer hold once treatment starts. Unplanned pregnancy on Mounjaro is a serious consideration. Tirzepatide is not recommended during pregnancy, and women of childbearing potential are advised to use effective contraception throughout treatment and during a wash-out period before trying to conceive, the exact duration should be discussed with your prescriber.

The MHRA's guidance on GLP-1 medicines makes clear these treatments have not been assessed for safety in pregnancy, and the recommendation is to stop treatment before conceiving. If you are thinking about your options more broadly, our Mounjaro overview covers the full clinical picture, and the Mounjaro and period bleeding page looks at what people in treatment commonly report.

If you are concerned about how Mounjaro fits with your overall health, including any mental health factors that intersect with weight, the Mounjaro and bulimia page discusses how prescribers approach treatment where eating behaviours are part of the picture. For cost context, the Mounjaro price comparison page explains what private treatment typically involves.

If you have questions your GP has not been able to answer, or you are considering starting treatment and want a prescriber to review your full situation, starting a free consultation with our clinical team is straightforward and reviewed the same day by a named GPhC-registered prescriber.